A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
N/A
The purpose of this study is to describe the characteristics of patients tr...
Status
Completed
Location
Local Institution
Start Date
2014-08
Trial ID
NCT02591732
Long-term Safety in Atrial Fibrillation Patients
PHASE2
The purpose of this study is to provide safety and tolerability data for AZ...
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
PHASE3
A study for patients with abnormal heart rhythm (atrial fibrillation) who n...
Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists
N/A
By evaluating routine clinical practice data from the UK primary care datab...
Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
N/A
Oral anticoagulant (OAC) treatment with either vitamin K antagonists (VKAs)...